122 related articles for article (PubMed ID: 31620191)
21. Vitamin D Modulates the Expression of IL-27 and IL-33 in the Central Nervous System in Experimental Autoimmune Encephalomyelitis (EAE).
Mohammadi-Kordkhayli M; Ahangar-Parvin R; Azizi SV; Nemati M; Shamsizadeh A; Khaksari M; Moazzeni SM; Jafarzadeh A
Iran J Immunol; 2015 Mar; 12(1):35-49. PubMed ID: 25784096
[TBL] [Abstract][Full Text] [Related]
22. Anti-IL-17A blocking antibody reduces cyclosporin A-induced relapse in experimental autoimmune encephalomyelitis mice.
Saitoh K; Kon S; Nakatsuru T; Inui K; Ihara T; Matsumoto N; Kitai Y; Muromoto R; Matsuda T
Biochem Biophys Rep; 2016 Dec; 8():139-145. PubMed ID: 28955949
[TBL] [Abstract][Full Text] [Related]
23. Alteration of T helper cell subsets in the optic nerve of experimental autoimmune encephalomyelitis.
Tian AY; Zhang RW; Shi XG; Yu HM
Int J Mol Med; 2010 Jun; 25(6):869-74. PubMed ID: 20428790
[TBL] [Abstract][Full Text] [Related]
24. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Wang Y; Mei Y; Feng D; Xu L
J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
[TBL] [Abstract][Full Text] [Related]
25. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
26. Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis.
Trubiani O; Giacoppo S; Ballerini P; Diomede F; Piattelli A; Bramanti P; Mazzon E
Stem Cell Res Ther; 2016 Jan; 7():1. PubMed ID: 26729060
[TBL] [Abstract][Full Text] [Related]
27. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
28. Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation.
Meng L; Ouyang J; Zhang H; Wen Y; Chen J; Zhou J
Restor Neurol Neurosci; 2011; 29(3):177-85. PubMed ID: 21586824
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
[TBL] [Abstract][Full Text] [Related]
30. Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis.
Peng Y; Zhu FZ; Chen ZX; Zhou JX; Gan L; Yang SS; Gao S; Liu QQ
Chin Med J (Engl); 2019 Dec; 132(24):2934-2940. PubMed ID: 31855963
[TBL] [Abstract][Full Text] [Related]
31. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
Front Immunol; 2018; 9():2588. PubMed ID: 30464764
[TBL] [Abstract][Full Text] [Related]
32. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
33. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Li M; Li Y; Liu X; Gao X; Wang Y
J Neuroimmunol; 2012 Jun; 247(1-2):25-31. PubMed ID: 22516472
[TBL] [Abstract][Full Text] [Related]
34. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
35. Strain specificities in age-related changes in mechanisms promoting and controlling rat spinal cord damage in experimental autoimmune encephalomyelitis.
Stojić-Vukanić Z; Pilipović I; Djikić J; Vujnović I; Nacka-Aleksić M; Bufan B; Arsenović-Ranin N; Kosec D; Leposavić G
Exp Gerontol; 2018 Jan; 101():37-53. PubMed ID: 29128575
[TBL] [Abstract][Full Text] [Related]
36. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
Samoilova EB; Horton JL; Chen Y
Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
[TBL] [Abstract][Full Text] [Related]
37. Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11-mediated protection of regulatory T cells.
Mondal S; Jana M; Dasarathi S; Roy A; Pahan K
Sci Signal; 2018 Nov; 11(558):. PubMed ID: 30482850
[TBL] [Abstract][Full Text] [Related]
38. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
39. Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Zheng Q; Yang T; Fang L; Liu L; Liu H; Zhao H; Zhao Y; Guo H; Fan Y; Wang L
BMC Complement Altern Med; 2015 Mar; 15():60. PubMed ID: 25887665
[TBL] [Abstract][Full Text] [Related]
40. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
